Molecular mechanism of ochratoxin A and ochratoxin A together with citrinin on human renal cells
Molecular mechanism of ochratoxin A and ochratoxin A together with citrinin on human renal cells
批准号:
250377076
负责人:
Professor Dr. Hans-Ulrich Humpf
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2014
资助国家:
德国
项目状态:
已结题
起止时间:
2013-12-31 至 2018-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Ochratoxin A and citrinin are metabolites of mould fungi growing on food and feed. Often they are found together in foodstuff generating a risk due to co-exposure. We could show that exposure to OTA in the nanomolar range led to a marked increase of the RNA expression of WISP1 (Wnt1 signaling pathway protein 1). Besides WISP1 also the expression of other genes involved in fibrosis or inflammation was elevated. First experiments show that the OTA-upregulated WISP1-RNA does not code for a protein but can bind the anti-fibrotic miR-29b, thereby disturbing its regulatory function. This new alternative WISP1 transcript contains putative binding sites for other miRNAs also and their relatedness to OTA toxicity remains to be determined. Additionally, the importance of the other OTA-regulated genes remains to be deter-mined.OTB, an OTA analogon without the chloride moiety, has no effect on the alternative WISP1-RNA expression. Therefore, it is extremely tantalizing and mechanistically relevant to characterize the role of this and other functional groups of the OTA molecule. By exchanging the chloride against other halogens and the phenylalanine against other amino acids, we are able to determine the impact of these groups for cell survival, fibrotic events and gene expression.OTA and citrinin can be found together in foodstuff. Therefore, a mutual influence on cell fate is conceivable. The harmful effects of one substance (OTA or citrinin) alone may be aggravated by additional stress, as caused by e.g. increased radical formation. We are able to determine the effects of a co-exposure of OTA and citrinin or OTA and other endogenously generated stressors as increased radical formation by measuring cell survival, fibrotic alterations, or dysregulated gene expression in human renal cells in primary culture.In summary therefore, it is necessary to determine(i) the role of the WISP1-RNA (and the other OTA-regulated genes) as well as to identify miRNAs which may interfere in OTA toxicity,(ii) the importance of functional groups of the OTA molecule using OTA analoga and to determine(iii) the potential risk emanating from co-exposure to the two mycotoxins together with endogenously generated cell stress.These investigations will be done using human renal cells mostly in primary culture.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Biosynthetic and toxic potential of ergot: Biological activity of ergot alkaloids and genome mining for the identification further potential toxic secondary metabolites
-
批准号:227350539
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Professor Dr. Hans-Ulrich Humpf
-
依托单位:
Thermal Reaction Products of Ochratoxin A: Metabolism and Bioavailability
-
批准号:188358540
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:Professor Dr. Hans-Ulrich Humpf
-
依托单位:
Studies on the occurence and biological activity of sphingolipids in food
-
批准号:5421422
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2004
-
负责人:Professor Dr. Hans-Ulrich Humpf
-
依托单位:
Occurrence and thermal stability of the mycotoxin citrinin
-
批准号:465450389
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Professor Dr. Hans-Ulrich Humpf
-
依托单位:
国内基金
海外基金
登录
查看更多内容
配子生成素GGN不同位点突变损伤分子伴侣BIP及HSP90B1功能导致精子形成障碍的发病机理
-
批准号:82371616
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姚晨成
-
依托单位:
糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
-
批准号:82371634
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵福军
-
依托单位:
生物钟核受体Rev-erbα在缺血性卒中神经元能量代谢中的改善作用及机制研究
-
批准号:82371332
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:胡琴
-
依托单位:
超声驱动压电效应激活门控离子通道促眼眶膜内成骨的作用及机制研究
-
批准号:82371103
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:阮静
-
依托单位:
骨髓ISG+NAMPT+中性粒细胞介导抗磷脂综合征B细胞异常活化的机制研究
-
批准号:82371799
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:杨程德
-
依托单位:
慢性炎症诱发骨丢失的机制及外泌体靶向治疗策略研究
-
批准号:82370889
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:傅德皓
-
依托单位:
PRNP调控巨噬细胞M2极化并减弱吞噬功能促进子宫内膜异位症进展的机制研究
-
批准号:82371651
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵栋
-
依托单位:
CBP/p300-HADH轴在基础胰岛素分泌调节中的作用和机制研究
-
批准号:82370798
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:王晓
-
依托单位:
5'-tRF-GlyGCC通过SRSF1调控RNA可变剪切促三阴性乳腺癌作用机制及干预策略
-
批准号:82372743
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陈卓佳
-
依托单位:
TIPE2调控巨噬细胞M2极化改善睑板腺功能障碍的作用机制研究
-
批准号:82371028
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵慧
-
依托单位: